Gene expression analysis demonstrates prognostic subtypes in metastatic pancreatic ductal adenocarcinoma (PDAC)

被引:1
|
作者
Wong, Hui-li
Karasinska, Joanna M.
Jones, Martin
Eirew, Peter
Schrader, Kasmintan
Lim, Howard
Shen, Yaoqing
Jones, Steven
Yip, Stephen
Laskin, Janessa
Marra, Marco
Schaeffer, David F.
Renouf, Daniel J.
机构
关键词
D O I
10.1158/1538-7445.PANCA16-B81
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B81
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Comprehensive genomic analysis in metastatic pancreatic ductal adenocarcinoma (PDAC).
    Wong, Hui-Li
    Jones, Martin
    Eirew, Peter
    Karasinska, Joanna
    Schrader, Kasmintan A.
    Lim, Howard John
    Shen, Yaoqing
    Jones, Steven
    Yip, Stephen
    Laskin, Janessa J.
    Marra, Marco
    Schaeffer, David F.
    Renouf, Daniel John
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [2] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 680 - 680
  • [3] Prognostic Metabolic Signatures in Pancreatic Ductal Adenocarcinoma (PDAC).
    Karasinska, Joanna
    Kalloger, Steve
    Wong, Hui-Li
    Renouf, Daniel
    Schaeffer, David
    [J]. MODERN PATHOLOGY, 2018, 31 : 680 - 680
  • [4] Clinically impactful metabolic subtypes of pancreatic ductal adenocarcinoma (PDAC)
    Pervin, Jannat
    Asad, Mohammad
    Cao, Shaolong
    Jang, Gun Ho
    Feizi, Nikta
    Haibe-Kains, Benjamin
    Karasinska, Joanna M.
    O'Kane, Grainne M.
    Gallinger, Steven
    Schaeffer, David F.
    Renouf, Daniel J.
    Zogopoulos, George
    Bathe, Oliver F.
    [J]. FRONTIERS IN GENETICS, 2023, 14
  • [5] Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)
    Sato, Daisuke
    Mitsuhashi, Tomoko
    Tsuchikawa, Takahiro
    Hatanaka, Yutaka
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    [J]. MODERN PATHOLOGY, 2015, 28 : 448A - 448A
  • [6] Stromal Palladin Expression Is an Independent Prognostic Factor of Pancreatic Ductal Adenocarcinoma (PDAC)
    Sato, Daisuke
    Mitsuhashi, Tomoko
    Tsuchikawa, Takahiro
    Hatanaka, Yutaka
    Nakamura, Toru
    Hirano, Satoshi
    Matsuno, Yoshihiro
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 448A - 448A
  • [7] Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
    Martinez-Muniz, Andres E.
    Sivanand, Sharanya
    Vander Heiden, Matthew
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [8] Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC)
    Norton, Carter
    Smith, Jarrod
    Rubnitz, Zach
    Tan, Grace H.
    Nevala-Plagemann, Christopher Duane
    Soares, Heloisa P.
    Garrido-Laguna, Ignacio
    Florou, Vaia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 619 - 619
  • [9] Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
    Parrasia, Sofia
    Zoratti, Mario
    Szabo, Ildiko
    Biasutto, Lucia
    [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2021, 55 (01) : 61 - 90
  • [10] Biomarker potential of collagens linked to fibroblast subtypes in pancreatic ductal adenocarcinoma (PDAC)
    Thorlacius-Ussing, J.
    Jensen, C.
    Karsdal, M.
    Willumsen, N.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1323 - S1324